# Colgate Palmolive Co: overview

CL · NYSE · CIK 21665 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cl.md) · [Financials](/companies/cl/financials.md) · [Filings](/companies/cl/filings.md) · [Insiders](/companies/cl/insiders.md)

Latest reported revenue: [$5.36bn](/filings/0000021665-26-000042.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000021665-26-000042).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,033](/filings/0000021665-25-000053.md) | [4,945 d](/filings/0000021665-26-000006.md) | [4,911](/filings/0000021665-26-000023.md) | [5,110](/filings/0000021665-26-000042.md) | [5,131](/filings/0000021665-25-000053.md) | [5,230 d](/filings/0000021665-26-000006.md) | [5,324](/filings/0000021665-26-000023.md) | [5,361](/filings/0000021665-26-000042.md) |
| Gross margin | % | [61.1%](/filings/0000021665-25-000053.md) | [60.3% d](/filings/0000021665-26-000006.md) | [60.8%](/filings/0000021665-26-000023.md) | [60.1%](/filings/0000021665-26-000042.md) | [59.4%](/filings/0000021665-25-000053.md) | [60.2% d](/filings/0000021665-26-000006.md) | [60.6%](/filings/0000021665-26-000023.md) | [61.5%](/filings/0000021665-26-000042.md) |
| Operating margin | % | [21.2%](/filings/0000021665-25-000053.md) | [21.5% d](/filings/0000021665-26-000006.md) | [21.9%](/filings/0000021665-26-000023.md) | [21.1%](/filings/0000021665-26-000042.md) | [20.6%](/filings/0000021665-25-000053.md) | [1.8% d](/filings/0000021665-26-000006.md) | [18.1%](/filings/0000021665-26-000023.md) | [19.0%](/filings/0000021665-26-000042.md) |
| Net margin | % | [14.6%](/filings/0000021665-25-000053.md) | [14.9% d](/filings/0000021665-26-000006.md) | [14.1%](/filings/0000021665-26-000023.md) | [14.5%](/filings/0000021665-26-000042.md) | [14.3%](/filings/0000021665-25-000053.md) | [(0.7%) d](/filings/0000021665-26-000006.md) | [12.1%](/filings/0000021665-26-000023.md) | [12.9%](/filings/0000021665-26-000042.md) |
| Diluted EPS | $ per share | [0.90](/filings/0000021665-25-000053.md) | not reported | [0.85](/filings/0000021665-26-000023.md) | [0.91](/filings/0000021665-26-000042.md) | [0.91](/filings/0000021665-25-000053.md) | not reported | [0.80](/filings/0000021665-26-000023.md) | [0.86](/filings/0000021665-26-000042.md) |
| Free cash flow | $m | [1,033 d](/filings/0000021665-25-000053.md) | [1,085 d](/filings/0000021665-26-000006.md) | [476](/filings/0000021665-26-000023.md) | [776 d](/filings/0000021665-26-000042.md) | [1,106 d](/filings/0000021665-25-000053.md) | [1,276 d](/filings/0000021665-26-000006.md) | [609](/filings/0000021665-26-000023.md) | [867 d](/filings/0000021665-26-000042.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [17.4](/filings/0000021665-24-000003.md) | [18.0](/filings/0000021665-25-000008.md) | [19.5](/filings/0000021665-26-000006.md) | [20.1](/filings/0000021665-26-000006.md) | [20.4](/filings/0000021665-26-000006.md) |
| Gross margin | % | [59.6%](/filings/0000021665-24-000003.md) | [57.0%](/filings/0000021665-25-000008.md) | [58.2%](/filings/0000021665-26-000006.md) | [60.5%](/filings/0000021665-26-000006.md) | [60.1%](/filings/0000021665-26-000006.md) |
| Operating margin | % | [19.1%](/filings/0000021665-24-000003.md) | [16.1%](/filings/0000021665-25-000008.md) | [20.5%](/filings/0000021665-26-000006.md) | [21.2%](/filings/0000021665-26-000006.md) | [16.2%](/filings/0000021665-26-000006.md) |
| Net margin | % | [12.4%](/filings/0000021665-24-000003.md) | [9.9%](/filings/0000021665-25-000008.md) | [11.8%](/filings/0000021665-26-000006.md) | [14.4%](/filings/0000021665-26-000006.md) | [10.5%](/filings/0000021665-26-000006.md) |
| Diluted EPS | $ per share | [2.55](/filings/0000021665-24-000003.md) | [2.13](/filings/0000021665-25-000008.md) | [2.77](/filings/0000021665-26-000006.md) | [3.51](/filings/0000021665-26-000006.md) | [2.63](/filings/0000021665-26-000006.md) |
| Free cash flow | $bn | [2.8](/filings/0000021665-24-000003.md) | [1.9](/filings/0000021665-25-000008.md) | [3.0](/filings/0000021665-26-000006.md) | [3.5](/filings/0000021665-26-000006.md) | [3.6](/filings/0000021665-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $6.41bn | 69,915,472 |  | Reduced −2,727,530 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.79bn | 52,246,333 |  | Added +26,509 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.31bn | 47,020,966 |  | Reduced −698,516 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.20bn | 24,021,137 |  | Added +198,391 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.14bn | 23,144,319 |  | Added +244,029 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.02bn | 22,072,925 |  | Added +1,191,571 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $1.24bn | 13,532,417 |  | Added +1,010,872 |
| [DEUTSCHE BANK AG\\](/funds/948046.md) | 2026-06-30 | $1.08bn | 11,751,973 |  | Reduced −176,188 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $888.0m | 9,686,029 |  | New +9,686,029 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $823.6m | 8,983,071 |  | Reduced −25,914 |

## Recent filings

[All 2,837 filings](/companies/cl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 07:56 ET | [8-K](/filings/0000021665-26-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000021665-26-000047 |
| 2026-07-31 | 08:32 ET | [10-Q](/filings/0000021665-26-000042.md) | Quarterly report, period 2026-06-30 | 0000021665-26-000042 |
| 2026-07-31 | 07:58 ET | [8-K](/filings/0000021665-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000021665-26-000041 |
| 2026-05-13 | 16:02 ET | [8-K](/filings/0000021665-26-000025.md) | 5.07 Shareholder vote results | 0000021665-26-000025 |
| 2026-05-01 | 08:16 ET | [10-Q](/filings/0000021665-26-000023.md) | Quarterly report, period 2026-03-31 | 0000021665-26-000023 |
| 2026-05-01 | 07:31 ET | [8-K](/filings/0000021665-26-000022.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000021665-26-000022 |
| 2026-04-09 | 08:22 ET | [8-K](/filings/0000021665-26-000015.md) | 5.02 Departure or appointment of officers or directors | 0000021665-26-000015 |
| 2026-03-25 | 08:15 ET | [DEF 14A](/filings/0001308179-26-000136.md) | Proxy statement, period 2026-05-08 | 0001308179-26-000136 |
| 2026-03-17 | 16:33 ET | [8-K](/filings/0000021665-26-000010.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000021665-26-000010 |
| 2026-03-12 | 16:33 ET | [8-K](/filings/0000021665-26-000008.md) | 5.02 Departure or appointment of officers or directors | 0000021665-26-000008 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000021665-26-000006.md), filed Feb 23, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f1e2df28-9dfc-45f2-998b-ad7e70db8629)

## About the filer

- CIK: 21665
- Tickers: CL
- Exchange: NYSE
- SIC code: 2844 Perfumes, Cosmetics & Other Toilet Preparations
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 08:32 ET. No prices; not investment advice.